Items where authors include "Coleman, R."

Article

Vogt, K.S., Johnson, J. orcid.org/0000-0003-0431-013X, Coleman, R. et al. (8 more authors) (2024) Can the Reboot coaching programme support critical care nurses in coping with stressful clinical events? A mixed-methods evaluation assessing resilience, burnout, depression and turnover intentions. BMC Health Services Research, 24. 343. ISSN 1472-6963

Johnson, J. orcid.org/0000-0003-0431-013X, Pointon, L., Talbot, R. et al. (11 more authors) (2023) Reboot coaching programme: a mixed-methods evaluation assessing resilience, confidence, burnout and depression in medical students. Scottish Medical Journal. ISSN 0036-9330

Velikova, G. orcid.org/0000-0003-1899-5942, Morden, J.P., Haviland, J.S. et al. (14 more authors) (2023) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology. ISSN 1470-2045

Al‐Ghunaim, T. orcid.org/0000-0001-8347-5148, Johnson, J. orcid.org/0000-0003-0431-013X, Biyani, C.S. orcid.org/0000-0003-3443-8425 et al. (3 more authors) (2023) Evaluation of the reboot coaching workshops among urology trainees: A mixed method approach. BJUI Compass, 4 (5). pp. 533-542. ISSN 2688-4526

Gillespie, S. A., Henderson, J., Abrahams, K. et al. (36 more authors) (2021) Coulomb excitation of and a change in structure approaching N = Z = 40. Physical Review C. 044313. ISSN 2469-9993

Clezardin, P. orcid.org/0000-0003-0149-4463, Coleman, R., Puppo, M. et al. (5 more authors) (2021) Bone metastasis : mechanisms, therapies and biomarkers. Physiological Reviews, 101 (3). pp. 797-855. ISSN 0031-9333

D'Oronzo, S., Gregory, W., Nicholson, S. et al. (3 more authors) (2021) Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences. Journal of Bone Oncology, 28. 100367. ISSN 2212-1374

Sestak, I., Blake, G., Patel, R. et al. (4 more authors) (2021) Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years : 7-year results from the IBIS-II prevention trial. British Journal of Cancer, 124 (8). pp. 1373-1378. ISSN 0007-0920

Coleman, R., Brown, J., Rathbone, E. et al. (9 more authors) (2020) CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON) : study protocol for a phase IB/IIA randomised controlled trial. Trials, 21 (1). 89.

Coleman, R. orcid.org/0000-0002-4275-1043 (2020) Bisphosphonates and breast cancer – from cautious palliation to saving lives. Bone, 140. 115570. ISSN 8756-3282

Savage, P., Winter, M. orcid.org/0000-0001-6192-9874, Parker, V. orcid.org/0000-0002-8748-4583 et al. (12 more authors) (2020) Demographics, natural history and treatment outcomes of non‐molar gestational choriocarcinoma; A UK population study. BJOG: An International Journal of Obstetrics & Gynaecology, 127 (9). pp. 1102-1107. ISSN 1470-0328

Kittaneh, M., Badve, S., Caldera, H. et al. (12 more authors) (2020) Case-based review and olinical guidance on the use of genomic assays for early-stage breast cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical Breast Cancer, 20 (3). pp. 183-193. ISSN 1526-8209

Coleman, R. orcid.org/0000-0002-4275-1043, Finkelstein, D.M., Barrios, C. et al. (14 more authors) (2020) Adjuvant denosumab in early breast cancer (D-CARE) : an international, multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology, 21 (1). pp. 60-72. ISSN 1470-2045

Coleman, R. orcid.org/0000-0002-4275-1043 (2019) Clinical benefits of bone targeted agents in early breast cancer. The Breast, 48 (Supplement 1). S92-S96. ISSN 0960-9776

D'Oronzo, S., Coleman, R., Brown, J. et al. (1 more author) (2019) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. Journal of Bone Oncology, 15. 100205. ISSN 2212-1366

Brown, J., Rathbone, E., Hinsley, S. et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. JNCI: Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Abraham, J., Coleman, R., Elias, A. et al. (9 more authors) (2018) Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG). Breast Cancer Research and Treatment, 171 (1). pp. 11-20. ISSN 0167-6806

Handforth, C., D'Oronzo, S., Coleman, R. et al. (1 more author) (2018) Cancer Treatment and Bone Health. Calcified Tissue International, 102 (2). pp. 251-264.

Abraham, J., Caldera, H., Coleman, R. et al. (11 more authors) (2018) Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast Cancer Research and Treatment, 169 (1). pp. 1-7. ISSN 0167-6806

Squires, H. orcid.org/0000-0002-2776-4014, Pandor, A., Thokala, P et al. (5 more authors) (2018) Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (1). pp. 29-38. ISSN 1170-7690

D'Oronzo, S., Brown, J. and Coleman, R. (2017) The role of biomarkers in the management of bone-homing malignancies. Journal of Bone Oncology, 9. pp. 1-9. ISSN 2212-1366

Cameron, D., Morden, J.P., Canney, P. et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

Coleman, R. orcid.org/0000-0002-4275-1043 (2016) Bone targeted treatments in cancer – The story so far. Journal of Bone Oncology, 5 (3). pp. 90-92. ISSN 2212-1374

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.

Pavlovic, M., Arnal-Estape, A., Rojo, F. et al. (16 more authors) (2015) Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis. JNCI: Journal of the National Cancer Institute, 107 (12). ARTN djv256. ISSN 0027-8874

Coleman, R. orcid.org/0000-0002-4275-1043, Aksnes, A-K., Naume, B. et al. (6 more authors) (2014) A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast Cancer Research and Treatment , 145 (2). pp. 411-418. ISSN 0167-6806

Hadji, P., Coleman, R. orcid.org/0000-0002-4275-1043, Gnant, M. et al. (1 more author) (2012) The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis. Annals of Oncology, 23 (11). pp. 2782-2790. ISSN 0923-7534

Coleman, R. orcid.org/0000-0002-4275-1043 and Hadji, P. (2012) Bone Oncology-An emerging multi-disciplinary specialty. Journal of Bone Oncology, 1 (1). p. 1. ISSN 2212-1366

Ring, A., Reed, M., Leonard, R. et al. (6 more authors) (2011) The treatment of early breast cancer in women over the age of 70. British Journal of Cancer, 105 (2). pp. 189-193. ISSN 0007-0920

Coleman, R. orcid.org/0000-0002-4275-1043, Woodward, E., Brown, J. et al. (11 more authors) (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment, 127 (2). pp. 429-438. ISSN 0167-6806

Coleman, R. orcid.org/0000-0002-4275-1043 and MacCallum, P. (2010) Treatment and secondary prevention of venous thromboembolism in cancer. British Journal of Cancer, 102. S17-S23. ISSN 0007-0920

Saxton, J.M., Daley, A., Woodroofe, N. et al. (5 more authors) (2006) Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment. BMC Cancer, 6 (35). ISSN 1471-2407

Vasey, P.A., Atkinson, R., Osborne, R. et al. (8 more authors) (2006) SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer. British Journal of Cancer, 94 (1). pp. 62-68. ISSN 0007-0920

Lester, J. and Coleman, R. orcid.org/0000-0002-4275-1043 (2005) Bone loss and the aromatase inhibitors. British Journal of Cancer, 93. S16-S22. ISSN 0007-0920

Serin, D., Verrill, M., Jones, A. et al. (6 more authors) (2005) Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study. British Journal of Cancer, 92 (11). pp. 1989-1996. ISSN 0007-0920

Clamp, A.R., Blackhall, F., Vasey, P. et al. (6 more authors) (2003) A phase II trial of bryostatin-I administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma. British Journal of Cancer, 89 (7). pp. 1152-1154. ISSN 0007-0920

Vasey, P.A., Atkinson, R., Coleman, R. orcid.org/0000-0002-4275-1043 et al. (9 more authors) (2001) Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. British Journal of Cancer, 84 (2). pp. 170-178. ISSN 0007-0920

Vinholes, J., Coleman, R. orcid.org/0000-0002-4275-1043, Lacombe, D. et al. (9 more authors) (1999) Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. British Journal of Cancer, 80 (1-2). pp. 221-228. ISSN 0007-0920

Thompson, P., Wilson, P., Osborne, R. et al. (9 more authors) (1991) The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. British Journal of Cancer, 64 (5). pp. 973-974. ISSN 0007-0920

Monograph

Beard, S.M., Coleman, R., Radford, J. et al. (1 more author) (1997) The use of Cisplatin and Paclitaxel as a first line treatment in ovarian cancer. Other. Guidance Notes for Purchasers (97/05). Trent Institute for Health Services Research, Universities of Leicester, Nottingham and Sheffield , Sheffield. ISSN 1900733129